Obligacje BMYB34
Poniżej znajduje się lista obligacji korporacyjnych BRISTOLMYERSDRN. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,45% | 15 K | 86,00% | 5,25% | 2043-08-15 | 4,064 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
 BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097 | 6,02% | 30 K | 119,38% | 6,88% | 2097-08-01 | 62,417 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. |
| BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 5,94% | 40 K | 87,86% | 5,00% | 2045-08-15 | 15,709 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,92% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,299 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5,89% | 100 K | 78,85% | 4,35% | 2047-11-15 | 13,567 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| US110122EC8BRIST.MYERS 23/63 | 5,69% | 0 | 113,18% | 6,40% | 2063-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5,67% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,204 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| US110122EL8BRIST.MYERS 24/64 | 5,60% | 0 | 100,93% | 5,65% | 2064-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122EB0BRIST.MYERS 23/53 | 5,53% | 0 | 111,62% | 6,25% | 2053-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122EK0BRIST.MYERS 24/54 | 5,45% | 0 | 101,57% | 5,55% | 2054-02-22 | 2,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043 | 5,43% | 620 K | 97,72% | 5,25% | 2043-08-15 | 218,373 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5754772Bristol-Myers Squibb Company FRN 20-FEB-2026 | 5,40% | 358 K | 100,21% | 5,57% | 2026-02-20 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 5,39% | 50 K | 90,21% | 4,63% | 2044-05-15 | 3,691 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047 | 5,33% | 225 K | 85,97% | 4,35% | 2047-11-15 | 1,236 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122EJ3BRIST.MYERS 24/44 | 5,33% | 0 | 102,23% | 5,50% | 2044-02-22 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BRMGBRISTOL-MYERS 13/44 | 5,31% | 0 | 89,67% | 4,50% | 2044-03-01 | 341,52 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040 | 5,29% | 9 K | 104,58% | 5,70% | 2040-10-15 | 151,011 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044 | 5,29% | 97 K | 91,42% | 4,63% | 2044-05-15 | 744,719 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY3883364Bristol-Myers Squibb Company 3.25% 01-AUG-2042 | 5,29% | 366 K | 75,38% | 3,25% | 2042-08-01 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 5,29% | 398 K | 96,14% | 5,00% | 2045-08-15 | 741,723 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 5,27% | 937 K | 89,56% | 4,55% | 2048-02-20 | 1,235 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 5,25% | 7,475 M | 84,88% | 4,25% | 2049-10-26 | 3,749 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122AP3BRISTOL-MYERS 2036 | 5,20% | 0 | 106,16% | 5,88% | 2036-11-15 | 279,22 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DX3BRIST.MYERS 22/62 | 5,19% | 0 | 75,52% | 3,90% | 2062-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DW5BRIST.MYERS 22/52 | 5,19% | 0 | 76,19% | 3,70% | 2052-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DV7BRIST.MYERS 22/42 | 5,17% | 0 | 80,54% | 3,55% | 2042-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 5,14% | 11,855 M | 89,25% | 4,13% | 2039-06-15 | 1,996 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038 | 5,13% | 20 K | 110,00% | 6,13% | 2038-05-01 | 219,255 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DR6BRIST.MYERS 20/40 | 5,12% | 0 | 68,52% | 2,35% | 2040-11-13 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DS4BRIST.MYERS 20/50 | 5,03% | 0 | 60,93% | 2,55% | 2050-11-13 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,00% | 50 K | 95,66% | 3,45% | 2027-11-15 | 16,548 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| US110122EH7BRIST.MYERS 24/34 | 4,97% | 0 | 101,74% | 5,20% | 2034-02-22 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DZ8BRIST.MYERS 23/33 | 4,94% | 0 | 107,11% | 5,90% | 2033-11-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DY1BRIST.MYERS 23/31 | 4,79% | 0 | 105,22% | 5,75% | 2031-02-01 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DU9BRIST.MYERS 22/32 | 4,78% | 0 | 88,54% | 2,95% | 2032-03-15 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122EG9BRIST.MYERS 24/31 | 4,73% | 0 | 102,01% | 5,10% | 2031-02-22 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,69% | 52 K | 97,60% | 3,90% | 2028-02-20 | 43,838 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
| US110122ED6BRIST.MYERS 24/26 | 4,57% | 0 | 100,47% | 4,95% | 2026-02-20 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | 4,55% | 7,407 M | 95,10% | 3,40% | 2029-07-26 | 2,373 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122EF1BRIST.MYERS 24/29 | 4,54% | 0 | 101,40% | 4,90% | 2029-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030 | 4,53% | 2,775 M | 83,69% | 1,45% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122EE4BRIST.MYERS 24/27 | 4,49% | 0 | 100,89% | 4,90% | 2027-02-22 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | 4,45% | 1,896 M | 98,33% | 3,90% | 2028-02-20 | 1,45 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| US110122DP0BRIST.MYERS 20/27 | 4,43% | 0 | 90,68% | 1,13% | 2027-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007341Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 4,42% | 6,78 M | 98,13% | 3,20% | 2026-06-15 | 1,744 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BRMJBRISTOL-MYERS 17/27 | 4,37% | 0 | 97,54% | 3,25% | 2027-02-27 | 512,277 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | 4,34% | 510 K | 97,48% | 3,45% | 2027-11-15 | 517,675 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY5007345Bristol-Myers Squibb Company 3.875% 15-AUG-2025 | 4,32% | 18 K | 99,56% | 3,88% | 2025-08-15 | 228,734 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026 | 4,21% | 75 K | 105,00% | 6,80% | 2026-11-15 | 255,948 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. |
| BMY5077466Bristol-Myers Squibb Company 0.75% 13-NOV-2025 | 4,15% | 816 K | 96,65% | 0,75% | 2025-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| XS122674851BRISTOL-MYERS 15/35 | 3,20% | 0 | 86,98% | 1,75% | 2035-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. |
| BMY4831828Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 2,64% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY4933148Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 2,47% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY4931963Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 2,47% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY4831826Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 2,30% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BRMHBRISTOL-MYERS 15/25 | 1,94% | 0 | 99,07% | 1,00% | 2025-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. |
| BMY4831822Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 0,52% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,953 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY4831824Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | −0,13% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,556 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY4945645Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | −1,13% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
| BMY4926518Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | −1,35% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |